Literature DB >> 25048578

Amyloid burden, cerebrovascular disease, brain atrophy, and cognition in cognitively impaired patients.

Byoung Seok Ye1, Sang Won Seo2, Geon Ha Kim3, Young Noh4, Hanna Cho5, Cindy W Yoon6, Hee Jin Kim7, Juhee Chin7, Seun Jeon8, Jong Min Lee8, Joon-Kyung Seong9, Jae Seung Kim10, Jae-Hong Lee11, Yearn Seong Choe12, Kyung Han Lee12, Young H Sohn13, Michael Ewers14, Michael Weiner15, Duk L Na7.   

Abstract

BACKGROUND: We investigated the independent effects of Alzheimer's disease (AD) and cerebrovascular disease (CVD) pathologies on brain structural changes and cognition.
METHODS: Amyloid burden (Pittsburgh compound B [PiB] retention ratio), CVD markers (volume of white matter hyperintensities [WMH] and number of lacunae), and structural changes (cortical thickness and hippocampal shape) were measured in 251 cognitively impaired patients. Path analyses were utilized to assess the effects of these markers on cognition.
RESULTS: PiB retention ratio was associated with hippocampal atrophy, which was associated with memory impairment. WMH were associated with frontal thinning, which was associated with executive and memory dysfunctions. PiB retention ratio and lacunae were also associated with memory and executive dysfunction without the mediation of hippocampal or frontal atrophy.
CONCLUSIONS: Our results suggest that the impacts of AD and CVD pathologies on cognition are mediated by specific brain regions.
Copyright © 2015 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amyloid; Atrophy; Cerebrovascular disease; Cognition; Cortical thickness; Hippocampus; Path analysis; Pittsburgh compound B

Mesh:

Substances:

Year:  2014        PMID: 25048578      PMCID: PMC5862069          DOI: 10.1016/j.jalz.2014.04.521

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  43 in total

1.  Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps.

Authors:  Liana G Apostolova; Rebecca A Dutton; Ivo D Dinov; Kiralee M Hayashi; Arthur W Toga; Jeffrey L Cummings; Paul M Thompson
Journal:  Arch Neurol       Date:  2006-05

2.  MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer's disease.

Authors:  D Mungas; W J Jagust; B R Reed; J H Kramer; M W Weiner; N Schuff; D Norman; W J Mack; L Willis; H C Chui
Journal:  Neurology       Date:  2001-12-26       Impact factor: 9.910

3.  Frontal lobe damage produces episodic memory impairment.

Authors:  M A Wheeler; D T Stuss; E Tulving
Journal:  J Int Neuropsychol Soc       Date:  1995-11       Impact factor: 2.892

4.  Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB.

Authors:  S M Resnick; J Sojkova; Y Zhou; Y An; W Ye; D P Holt; R F Dannals; C A Mathis; W E Klunk; L Ferrucci; M A Kraut; D F Wong
Journal:  Neurology       Date:  2010-02-10       Impact factor: 9.910

5.  Clinico-neuropathological correlation of Alzheimer's disease in a community-based case series.

Authors:  A Lim; D Tsuang; W Kukull; D Nochlin; J Leverenz; W McCormick; J Bowen; L Teri; J Thompson; E R Peskind; M Raskind; E B Larson
Journal:  J Am Geriatr Soc       Date:  1999-05       Impact factor: 5.562

6.  Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology.

Authors:  J A Schneider; R S Wilson; J L Bienias; D A Evans; D A Bennett
Journal:  Neurology       Date:  2004-04-13       Impact factor: 9.910

7.  Seoul Neuropsychological Screening Battery-dementia version (SNSB-D): a useful tool for assessing and monitoring cognitive impairments in dementia patients.

Authors:  Hyun-Jung Ahn; Juhee Chin; Aram Park; Byung Hwa Lee; Mee Kyung Suh; Sang Won Seo; Duk L Na
Journal:  J Korean Med Sci       Date:  2010-06-17       Impact factor: 2.153

8.  Amyloid deposition is associated with impaired default network function in older persons without dementia.

Authors:  Reisa A Sperling; Peter S Laviolette; Kelly O'Keefe; Jacqueline O'Brien; Dorene M Rentz; Maija Pihlajamaki; Gad Marshall; Bradley T Hyman; Dennis J Selkoe; Trey Hedden; Randy L Buckner; J Alex Becker; Keith A Johnson
Journal:  Neuron       Date:  2009-07-30       Impact factor: 17.173

9.  MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging.

Authors:  F Fazekas; J B Chawluk; A Alavi; H I Hurtig; R A Zimmerman
Journal:  AJR Am J Roentgenol       Date:  1987-08       Impact factor: 3.959

10.  Amyloid-β associated cortical thinning in clinically normal elderly.

Authors:  J Alex Becker; Trey Hedden; Jeremy Carmasin; Jacqueline Maye; Dorene M Rentz; Deepti Putcha; Bruce Fischl; Douglas N Greve; Gad A Marshall; Stephen Salloway; Donald Marks; Randy L Buckner; Reisa A Sperling; Keith A Johnson
Journal:  Ann Neurol       Date:  2011-03-17       Impact factor: 10.422

View more
  27 in total

1.  Distinct White Matter Changes Associated with Cerebrospinal Fluid Amyloid-β1-42 and Hypertension.

Authors:  Omar M Al-Janabi; Christopher A Brown; Ahmed A Bahrani; Erin L Abner; Justin M Barber; Brian T Gold; Larry B Goldstein; Ronan R Murphy; Peter T Nelson; Nathan F Johnson; Leslie M Shaw; Charles D Smith; John Q Trojanowski; Donna M Wilcock; Gregory A Jicha
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

2.  Imaging Vascular Disease and Amyloid in the Aging Brain: Implications for Treatment.

Authors:  Sylvia Villeneuve; William J Jagust
Journal:  J Prev Alzheimers Dis       Date:  2015-03

3.  Revised Framingham Stroke Risk Profile: Association with Cognitive Status and MRI-Derived Volumetric Measures.

Authors:  Isabelle Pelcher; Christian Puzo; Yorghos Tripodis; Hugo J Aparicio; Eric G Steinberg; Alyssa Phelps; Brett Martin; Joseph N Palmisano; Elizabeth Vassey; Cutter Lindbergh; Ann C McKee; Thor D Stein; Ronald J Killiany; Rhoda Au; Neil W Kowall; Robert A Stern; Jesse Mez; Michael L Alosco
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

4.  Application of an amyloid and tau classification system in subcortical vascular cognitive impairment patients.

Authors:  Hyemin Jang; Hee Jin Kim; Seongbeom Park; Yu Hyun Park; Yeongsim Choe; Hanna Cho; Chul Hyoung Lyoo; Uicheul Yoon; Jin San Lee; Yeshin Kim; Seung Joo Kim; Jun Pyo Kim; Young Hee Jung; Young Hoon Ryu; Jae Yong Choi; Seung Hwan Moon; Joon-Kyung Seong; Charles DeCarli; Michael W Weiner; Samuel N Lockhart; Soo Hyun Cho; Duk L Na; Sang Won Seo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-08-31       Impact factor: 9.236

5.  Effects of amyloid and vascular markers on cognitive decline in subcortical vascular dementia.

Authors:  Byoung Seok Ye; Sang Won Seo; Jung-Hyun Kim; Geon Ha Kim; Hanna Cho; Young Noh; Hee Jin Kim; Cindy W Yoon; Sook-Young Woo; Sook Hui Kim; Hee Kyung Park; Sung Tae Kim; Yearn Seong Choe; Kyung Han Lee; Jae Seung Kim; Seung Jun Oh; Changsoo Kim; Michael Weiner; Jae-Hong Lee; Duk L Na
Journal:  Neurology       Date:  2015-10-14       Impact factor: 9.910

Review 6.  Impact of multiple pathologies on the threshold for clinically overt dementia.

Authors:  Alifiya Kapasi; Charles DeCarli; Julie A Schneider
Journal:  Acta Neuropathol       Date:  2017-05-09       Impact factor: 17.088

Review 7.  60 Years of Achievements by KSNM in Neuroimaging Research.

Authors:  Jae Seung Kim; Hye Joo Son; Minyoung Oh; Dong Yun Lee; Hae Won Kim; Jungsu Oh
Journal:  Nucl Med Mol Imaging       Date:  2022-01-15

8.  Association of β-Amyloid and Basal Forebrain With Cortical Thickness and Cognition in Alzheimer and Lewy Body Disease Spectra.

Authors:  Han Soo Yoo; Seun Jeon; Enrica Cavedo; MinJin Ko; Mijin Yun; Phil Hyu Lee; Young H Sohn; Michel J Grothe; Stefan Teipel; Harald Hampel; Alan C Evans; Byoung Seok Ye
Journal:  Neurology       Date:  2021-12-30       Impact factor: 9.910

9.  Association of β-Amyloid and Vascular Risk on Longitudinal Patterns of Brain Atrophy.

Authors:  Jennifer S Rabin; Jeremy Pruzin; Matthew Scott; Hyun-Sik Yang; Olivia Hampton; Stephanie Hsieh; Aaron P Schultz; Rachel F Buckley; Trey Hedden; Dorene Rentz; Keith A Johnson; Reisa A Sperling; Jasmeer P Chhatwal
Journal:  Neurology       Date:  2022-04-26       Impact factor: 11.800

10.  Selective loss of cortical endothelial tight junction proteins during Alzheimer's disease progression.

Authors:  Yu Yamazaki; Mitsuru Shinohara; Motoko Shinohara; Akari Yamazaki; Melissa E Murray; Amanda M Liesinger; Michael G Heckman; Elizabeth R Lesser; Joseph E Parisi; Ronald C Petersen; Dennis W Dickson; Takahisa Kanekiyo; Guojun Bu
Journal:  Brain       Date:  2019-04-01       Impact factor: 15.255

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.